Medicines and Healthcare products Regulatory Agency forces ‘CBD Products To Be Removed From Sale in UK’

‘The pharmaceuticalisation of CBD Products?
Today news swept across the internet and social media that Cannabidiol (CBD), the non-psychoactive cannabinoid, is going to be scheduled as a medicine.
A number of CBD companies have received letters from the Medicines and Healthcare products Regulatory Agency (MHRA) notifying them that they will have to cease selling CBD Products on November 1st 2016.
Many patients across the UK have now been struck with worry that the only legal access to cannabis products, and their only source of relief from a variety of ailments, is going to be taken away from them.’
Read more: Medicines and Healthcare products Regulatory Agency forces ‘CBD Products To Be Removed From Sale in UK’